Table 3

Results of multilevel multinomial logistic regression analysis predicting cluster membership
Diabetes-related healthcare
Profile 1 ‘high utilisation and frequent home visits’ Profile 3 ‘high utilisation, GP and nurse’ Profile 1 ‘high utilisation and frequent home visits’
(Profile 2 ‘low utilisation, GP only’= reference group) (Profile 2 ‘low utilisation, GP only’= reference group) (Profile 3 ‘high utilisation, GP and nurse’= reference group)
Patient and disease characteristics Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI)
Gender (reference male) 1.80 (1.38-2.34) 0.92 (0.83-1.02) 2.27 (1.76-2.93)
Age (reference 18–44)
45-54 0.43 (0.09-1.92) 1.46 (1.12-1.90) 0.35 (0.07-1.72)
55-64 0.71 (0.21-2.41) 1.64 (1.29-2.10) 0.48 (0.13-1.82)
65-74 3.24 (1.08-9.69) 1.74 (1.36-2.22) 2.22 (0.67-7.39)
75 and older 16.20 (5.55-47.27) 1.26 (0.98-1.62) 15.47 (4.76-50.27)
Urbanisation (reference: 2500 or more addresses per square km)
1500-2499 addresses per square km 0.61 (0.38-0.99) 1.19 (0.94-1.52) 0.57 (0.36-0.90)
1000-1499 addresses per square km 0.69 (0.40-1.21) 1.11 (0.83-1.48) 0.65 (0.38-1.10)
500-999 addresses per square km 0.58 (0.30-1.12) 1.14 (0.82-1.60) 0.53 (0.28-1.00)
<500 addresses per square km 0.66 (0.34-1.29) 1.17 (0.80-1.72) 0.60 (0.32-1.15)
Main medication form (reference: no medication)
Oral medication only 2.16 (1.58-2.96) 1.61 (1.43-1.82) 1.53 (1.13-2.06)
Oral medication and insulin 3.46 (2.35-5.10) 1.15 (0.96-1.37) 3.24 (2.25-4.67)
Related comorbidity
Heart diseases 1.04 (0.76-1.44) 0.99 (0.85-1.15) 1.14 (0.85-1.53)
Stroke 1.90 (1.25-2.89) 0.76 (0.57-1.01) 2.92 (2.00-4.27)
Retinopathy 1.28 (0.37-4.50) 1.43 (0.73-2.82) 0.55 (0.14-2.18)
Nephropathy 1.34 (0.78-2.28) 0.88 (0.62-1.24) 1.65 (1.00-2.70)
Diabetic foot 1.01 (0.48-2.11) 0.88 (0.61-1.27) 1.21 (0.62-2.36)
Non-related comorbidity
Depression 1.50 (0.96-2.35) 1.03 (0.80-1.32) 1.72 (1.15-2.56)
Lung diseases 1.44 (1.04-1.98) 1.00 (0.85-1.18) 1.40 (1.03-1.89)
Musculoskeletal diseases 1.20 (0.94-1.55) 1.05 (0.94-1.17) 1.20 (0.95-1.51)
Neurological diseases 1.06 (0.45-2.49) 0.75 (0.46-1.22) 1.89 (0.91-3.91)
Cancer 1.34 (0.84-2.14) 0.80 (0.61-1.06) 1.84 (1.20-2.82)

van Dijk et al.

van Dijk et al. BMC Health Services Research 2013 13:7   doi:10.1186/1472-6963-13-7

Open Data